PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers synthesize a new allotrope of carbon

2025-08-14
(Press-News.org) Images available via the multimedia section.

Chemists have demonstrated the synthesis of a new molecular form of carbon. The new molecule – cyclo[48]carbon, made up of 48 carbon atoms in an alternating single/triple bond pattern – is stable enough to be studied in liquid solution form at room temperature. The study – only the second example of a new type of molecular carbon allotrope that can be studied under normal laboratory conditions – has been published today (14 August) in Science. In a new study led by Oxford University’s Department of Chemistry, chemists have demonstrated the synthesis of a cyclocarbon that is stable enough for spectroscopic characterisation in solution at room temperature.

The synthesis of a new type of molecular carbon allotrope that can be studied under normal laboratory conditions is a rare achievement. The only previous example was the synthesis of fullerenes by Krätschmer et al. in 1990 (Nature 1990).

In the new study, the molecule cyclo[48]carbon was synthesised as a [4]catenane, i.e. with the C48 ring threaded through three other macrocycles. These threaded macrocycles increase the stability of C48 by preventing access to the protected cyclocarbon.

Previously, molecular rings consisting purely of carbon atoms have only been studied in the gas phase or at very low temperatures (4 to 10 K). Now, the team have synthesised a cyclocarbon that is stable in solution at 20°C (half-life 92 hours). This has been achieved by using threaded macrocycles, choosing a large cyclocarbon with a low level of strain, and developing mild reaction conditions for the unmasking step in the reaction (where a precursor molecule is transformed into the final product).

The cyclocarbon catenane was characterised by mass spectrometry, NMR, UV-visible and Raman spectroscopy. The observation of a single intense 13C NMR resonance for all 48 sp1 carbon atoms indicates that all of the carbons are in equivalent environments, which provides strong evidence for the cyclocarbon catenane structure.

Lead author Dr Yueze Gao (Department of Chemistry, University of Oxford) said: “Achieving stable cyclocarbons in a vial at ambient conditions is a fundamental step. This will make it easier to study their reactivity and properties under normal laboratory conditions.”

Study senior author Professor Harry Andersen (Department of Chemistry, University of Oxford) said: “This achievement marks the culmination of a long endeavour to synthesise cyclocarbon catenanes, based on the hope that they might be stable enough to study at room temperature. The original grant proposal was written in 2016, based on preliminary results from 2012–2015. It is satisfying to have reached this point, because there were many times when the goal seemed unrealistic and unachievable. This work would not have been possible without the outstanding facilities for NMR spectroscopy in the Department of Chemistry at Oxford.”

The study also involved researchers from the University of Manchester, the University of Bristol and the Central Laser Facility, Rutherford Appleton Laboratory.

Notes to editors:

For media enquiries and interview requests, contact: Professor Harry Anderson: harry.anderson@chem.ox.ac.uk

The study ‘Solution-phase stabilization of a cyclocarbon by catenane formation’ will be published in Science at 19:00 BEST / 14:00 ET on Thursday 14 August at https://doi.org/10.1126/science.ady6054

Advance copies of the paper may be obtained from the Science press package, SciPak, at https://www.eurekalert.org/press/scipak/ or by contacting scipak@aaas.org

About the University of Oxford

Oxford University has been placed number 1 in the Times Higher Education World University Rankings for the ninth year running, and number 3 in the QS World Rankings 2024. At the heart of this success are the twin-pillars of our ground-breaking research and innovation and our distinctive educational offer.

Oxford is world-famous for research and teaching excellence and home to some of the most talented people from across the globe. Our work helps the lives of millions, solving real-world problems through a huge network of partnerships and collaborations. The breadth and interdisciplinary nature of our research alongside our personalised approach to teaching sparks imaginative and inventive insights and solutions.

Through its research commercialisation arm, Oxford University Innovation, Oxford is the highest university patent filer in the UK and is ranked first in the UK for university spinouts, having created more than 300 new companies since 1988. Over a third of these companies have been created in the past five years. The university is a catalyst for prosperity in Oxfordshire and the United Kingdom, contributing around £16.9 billion to the UK economy in 2021/22, and supports more than 90,400 full time jobs.

END


ELSE PRESS RELEASES FROM THIS DATE:

Scientists hack microbes to identify environmental sources of methane

2025-08-14
Roughly two-thirds of all emissions of atmospheric methane — a highly potent greenhouse gas that is warming planet Earth — come from microbes that live in oxygen-free environments like wetlands, rice fields, landfills and the guts of cows. Tracking atmospheric methane to its specific sources and quantifying their importance remains a challenge, however. Scientists are pretty good at tracing the sources of the main greenhouse gas, carbon dioxide, to focus on mitigating these emissions. But to trace methane’s origins, scientists often have to measure the isotopic composition of methane's component atoms, carbon and hydrogen, to ...

New high blood pressure guideline emphasizes prevention, early treatment to reduce CVD risk

2025-08-14
Guideline Highlights: Nearly half of all adults in the U.S. have high blood pressure (≥130/80 mm Hg), which is the #1 preventable risk factor for cardiovascular disease, including heart attack, stroke and heart failure, as well as kidney disease, cognitive decline and dementia. A new joint guideline from the American Heart Association and the American College of Cardiology advises earlier treatment that includes lifestyle modification and medications as appropriate, recommends close blood pressure ...

"Every Brilliant Thing”, the interactive one-person play with a suicidality theme now making its West End debut, reduced suicide-associated stigma among university students who attended, even up to 30

2025-08-14
"Every Brilliant Thing”, the interactive one-person play with a suicidality theme now making its West End debut, reduced suicide-associated stigma among university students who attended, even up to 30 days later. +++ Article URL: https://plos.io/411ECQu Article Title: A performing arts intervention to decrease suicide stigma on campus: A three time point assessment of “Every Brilliant Thing” Author Countries: United States Funding: The authors received no specific funding for this ...

Climate models reveal human influence behind stalled pacific cycle

2025-08-14
A new CU Boulder-led study has revealed that recent changes in North Pacific Ocean temperatures—long believed to be the result of natural variability—are in fact being driven by human-generated greenhouse gas and industrial aerosol emissions. These oceanic shifts are directly linked to the prolonged megadrought gripping the American Southwest, and this research published August 13th in Nature suggests it may not ease for another 30 years. “Our results show that the drought and ocean patterns we’re seeing today are not just natural fluctuations—they’re largely driven by human activity,” ...

Laying the foundation for gene editing for inherited progressive deafness in adults, DFNA41

2025-08-14
Zheng-Yi Chen, DPhil, associate scientist at the Eaton-Peabody Laboratories, and Ines and Fredrick Yeatts Chair in Otolaryngology, at Mass Eye and Ear, is the senior and co-corresponding author of a paper published in the Journal of Clinical Investigation, “Single Dose Genome Editing Therapy Rescues Auditory and Vestibular Functions in Adult Mice with DFNA41 Deafness.” Q: How would you summarize your study for a lay audience? This study provides an example of a successful use of gene editing technology to treat a mouse model of human genetic hearing loss. We developed a one-time, gene editing ...

Monell Center researchers present latest findings at International Meeting on Consumer Sensory Science

2025-08-14
Monell Center Researchers Present Latest Findings at International Meeting On Consumer Sensory Science Coinciding with the 2025 Philadelphia-based conference, Monell - the first independent nonprofit dedicated to smell and taste research - hosts academic, industry partners for visits, collaborations  PHILADELPHIA (Aug 14, 2025) – Scientists from the Monell Chemical Senses Center will present their research at the 16th Pangborn Sensory Science Symposium, “Connecting Senses and Minds,” August 17-21, 2025 ...

AFAR receives NIH award renewal totaling more than $5.7 million for the Nathan Shock Centers Coordinating Center

2025-08-14
NEW YORK — The American Federation for Aging Research (AFAR) has received a five-year renewal award totaling $5,722,435 from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to continue and expand the Nathan Shock Centers Coordinating Center (NSC3). The NSC3 coordinates the activities of the 8 Nathan Shock Centers (NSC) of Excellence in the Basic Biology of Aging, which provide expert resources to expand basic research into the biology of aging. The NSCs began in 1995 in honor of ...

Brain-computer interface could decode inner speech in real time

2025-08-14
Scientists have pinpointed brain activity related to inner speech—the silent monologue in people’s heads—and successfully decoded it on command with up to 74% accuracy. Publishing August 14 in the Cell Press journal Cell, their findings could help people who are unable to audibly speak communicate more easily using brain-computer interface (BCI) technologies that begin translating inner thoughts when a participant says a password inside their head.  “This is the first time ...

Cancer drug eliminates aggressive cancers in clinical trial

2025-08-14
Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise—and induced great disappointment. While effective at activating the immune system to kill cancer cells in animal models, the drugs had limited impact on patients in clinical trials and caused dangerously systemic inflammatory responses, low platelet counts, and liver toxicity, among other adverse reactions—even at a low dose. But in 2018, the lab of Rockefeller University’s Jeffrey V. Ravetch demonstrated it could engineer an enhanced CD40 ...

Ancient cephalopod, new insight: Nautilus reveals unexpected sex chromosome system

2025-08-14
Nautiloids—a lineage of ancient, externally-shelled cephalopods that diverged from their octopus and squid relatives over 400 million years ago—once dominated our oceans. Today, this living fossil is restricted to a handful of species in the Southern Indo-Pacific, making it one of the few marine invertebrates listed under CITES appendix II of species in need of protection from over-exploitation.. Although no one had previously investigated sex determination systems in cephalopods, recent research suggested a ZZ/Z0 ...

LAST 30 PRESS RELEASES:

ORC2 regulation of human gene expression shows unexpected breadth and scale

Researchers track how iron deficiency disrupts photosynthesis in crucial ocean algae

A Mount Sinai-Led team creates model for understanding how the brain’s decision-making is impacted in psychiatric disorders

A new way to study omega fatty acids

Targeting ferroptosis in cancer stem cells: A promising approach to enhance cancer treatment

As the atmosphere changes, so will its response to geomagnetic storms

First transfer of behavior between species through single gene manipulation

A new network could help predict health problems in your pup

Connecting biofuel and conservation policies

Deep learning model successfully predicted ignition in inertial confinement fusion experiment

Maternal antibodies in breast milk regulate early immune responses in mouse gut

Densely planted maize communicates with neighboring plants to defend against pests

Paper: Decarbonize agriculture by expanding policies aimed at low-carbon biofuels

New tech speeds up AI training for drug discovery/disease research

Researchers synthesize a new allotrope of carbon

Scientists hack microbes to identify environmental sources of methane

New high blood pressure guideline emphasizes prevention, early treatment to reduce CVD risk

"Every Brilliant Thing”, the interactive one-person play with a suicidality theme now making its West End debut, reduced suicide-associated stigma among university students who attended, even up to 30

Climate models reveal human influence behind stalled pacific cycle

Laying the foundation for gene editing for inherited progressive deafness in adults, DFNA41

Monell Center researchers present latest findings at International Meeting on Consumer Sensory Science

AFAR receives NIH award renewal totaling more than $5.7 million for the Nathan Shock Centers Coordinating Center

Brain-computer interface could decode inner speech in real time

Cancer drug eliminates aggressive cancers in clinical trial

Ancient cephalopod, new insight: Nautilus reveals unexpected sex chromosome system

MIT researchers use generative AI to design compounds that can kill drug-resistant bacteria

Alzheimer’s disease pathology and potential treatment targets identified in brain organoids

1 in 3 US adults unaware of connection between HPV and cancers

State-level public awareness of HPV, HPV vaccine, and association with cancer

Mayo Clinic researchers discover the immune system's 'fountain of youth'

[Press-News.org] Researchers synthesize a new allotrope of carbon